Motley Fool Mid-Cap Growth ETF Rating $27.06 +1.11 (+4.28%) As of 01/21/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHeadlinesHoldingsOwnershipRatings Motley Fool Mid-Cap Growth ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.TMFM Aggregate RatingModerate Buy 2.56Holdings in TMFM have an aggregate rating of Moderate Buy based on 373 analyst ratings issued in the past year covering 29 companies (91.5% of the portfolio).TMFM Aggregate Price Target$27.06High Prediction$27.06Average Prediction$27.06Low Prediction$27.06Holdings in TMFM have an aggregate price target of $27.06 and a range of $27.06 to $27.06 covering 29 companies (91.5% of the portfolio).TMFM Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold10 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Motley Fool Mid-Cap Growth ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 29 TMFM Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.30%GMEDGlobus Medical$92.33+1.7%4.4242 of 5 stars2.75$96.91 5.0%12Positive News4.98%BROBrown & Brown$105.75+0.2%4.1498 of 5 stars2.50$112.08 6.0%12Upcoming Earnings4.67%HQYHealthEquity$104.74+2.3%2.9412 of 5 stars2.93$110.71 5.7%144.66%AXONAxon Enterprise$605.58+2.0%3.248 of 5 stars3.00$504.92 -16.6%14Positive News4.63%BRBroadridge Financial Solutions$233.93+1.5%4.6605 of 5 stars2.38$226.71 -3.1%8News CoveragePositive News4.22%TYLTyler Technologies$584.69+2.7%4.8646 of 5 stars2.79$643.77 10.1%14Analyst ForecastPositive News4.02%TOSTToast$38.67+2.1%2.4197 of 5 stars2.39$35.27 -8.8%23Positive News3.74%WATWaters$413.63+2.4%4.4073 of 5 stars2.33$384.71 -7.0%15High Trading Volume3.72%RXORXO$25.88+2.7%1.8876 of 5 stars2.07$26.77 3.4%153.62%SBACSBA Communications$204.36+0.4%4.6703 of 5 stars2.77$254.77 24.7%13Positive News3.52%COOCooper Companies$95.35+2.2%2.9771 of 5 stars2.75$117.00 22.7%123.50%DXCMDexCom$86.32+2.3%4.9706 of 5 stars2.89$99.29 15.0%18Gap Up3.40%ALRMAlarm.com$62.13+1.3%2.4765 of 5 stars2.17$64.40 3.7%63.28%WSOWatsco$505.29+1.8%3.8928 of 5 stars2.40$488.33 -3.4%5Analyst Revision3.25%HRIHerc$209.93+2.0%3.1117 of 5 stars2.50$219.75 4.7%4Positive News3.24%GWREGuidewire Software$181.54+1.7%4.119 of 5 stars2.71$193.00 6.3%14Insider TradeNews Coverage3.03%FASTFastenal$76.09+0.0%4.4377 of 5 stars1.91$76.91 1.1%11Earnings ReportDividend IncreaseAnalyst ForecastShort Interest ↑2.73%GSHDGoosehead Insurance$106.32-3.7%3.4201 of 5 stars2.40$99.20 -6.7%10Gap Down2.70%MORNMorningstar$330.91+1.1%3.6018 of 5 stars2.67$360.67 9.0%3High Trading Volume2.63%GXOGXO Logistics$45.23+2.9%4.1351 of 5 stars2.77$65.38 44.6%132.47%TRUTransUnion$96.33+1.1%4.8685 of 5 stars2.63$108.19 12.3%162.44%CSGPCoStar Group$74.16+0.4%4.3719 of 5 stars2.77$92.92 25.3%13Short Interest ↑2.42%GNTXGentex$28.35+1.4%4.493 of 5 stars2.38$35.13 23.9%82.41%EMNEastman Chemical$94.37+1.2%4.9785 of 5 stars2.54$112.92 19.7%132.25%TREXTrex$72.85+1.7%1.9858 of 5 stars2.31$79.81 9.6%16News Coverage2.21%TSCOTractor Supply$56.88+6.0%3.9439 of 5 stars2.57$58.01 2.0%23High Trading Volume1.72%AREAlexandria Real Estate Equities$102.75+0.9%4.7119 of 5 stars2.27$121.90 18.6%11Upcoming EarningsPositive News0.38%BMRNBioMarin Pharmaceutical$62.53+1.6%4.9978 of 5 stars2.74$94.20 50.6%23Analyst Revision0.34%RAREUltragenyx Pharmaceutical$41.28+3.2%4.6102 of 5 stars2.93$92.29 123.6%14 This page (BATS:TMFM) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredThe Crypto Secret Wall Street Doesn’t Want You to KnowPotential $20-trillion opportunity? Put $500 into THIS AI Coin for 2025… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Motley Fool Mid-Cap Growth ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Motley Fool Mid-Cap Growth ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
